These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 27207509

  • 21. Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation.
    Banerjee D, Sinha A, Saikia S, Gogoi B, Rathore AK, Das AS, Pal D, Buragohain AK, Dasgupta S.
    Biochimie; 2018 Aug; 151():139-149. PubMed ID: 29883748
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
    Misra UK, Pizzo SV.
    J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition.
    Han EK, Leverson JD, McGonigal T, Shah OJ, Woods KW, Hunter T, Giranda VL, Luo Y.
    Oncogene; 2007 Aug 16; 26(38):5655-61. PubMed ID: 17334390
    [Abstract] [Full Text] [Related]

  • 28. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
    Masui K, Tanaka K, Akhavan D, Babic I, Gini B, Matsutani T, Iwanami A, Liu F, Villa GR, Gu Y, Campos C, Zhu S, Yang H, Yong WH, Cloughesy TF, Mellinghoff IK, Cavenee WK, Shaw RJ, Mischel PS.
    Cell Metab; 2013 Nov 05; 18(5):726-39. PubMed ID: 24140020
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.
    Zhang D, Tong X, Arthurs B, Guha A, Rui L, Kamath A, Inoki K, Yin L.
    J Biol Chem; 2014 Sep 12; 289(37):25925-35. PubMed ID: 25063808
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
    Tzatsos A, Kandror KV.
    Mol Cell Biol; 2006 Jan 12; 26(1):63-76. PubMed ID: 16354680
    [Abstract] [Full Text] [Related]

  • 34. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
    Hsieh CT, Chuang JH, Yang WC, Yin Y, Lin Y.
    Cell Signal; 2014 Jul 12; 26(7):1400-8. PubMed ID: 24650522
    [Abstract] [Full Text] [Related]

  • 35. Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling.
    Tao R, Xiong X, Liangpunsakul S, Dong XC.
    Diabetes; 2015 Apr 12; 64(4):1211-23. PubMed ID: 25377878
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A, Usui I, Haruta T, Kawahara J, Uno T, Iwata M, Kobayashi M.
    Mol Cell Biol; 2001 Aug 12; 21(15):5050-62. PubMed ID: 11438661
    [Abstract] [Full Text] [Related]

  • 40. Activation of mTORC2 by association with the ribosome.
    Zinzalla V, Stracka D, Oppliger W, Hall MN.
    Cell; 2011 Mar 04; 144(5):757-68. PubMed ID: 21376236
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.